Compare CVS Health Corp (CVS) vs Sezzle Inc (SEZL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Sezzle Inc — how do they compare? CVS Health Corp trades at $87.11 (market cap $112.29B), while Sezzle Inc trades at $126.38 (market cap $3.95B). The key difference: CVS Health Corp is far larger — about 28.4× Sezzle Inc's market cap, and CVS Health Corp pays a 3.03% dividend while Sezzle Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Sezzle Inc for 15 Days on average.
| CVS | SEZL | |
|---|---|---|
Market Cap | $112.29B | $3.95B |
Volume | 7,763,676 | 550,075 |
Sector | Health | Financials |
52-Week High | $110.60 | $188.55 |
52-Week Low | $70.08 | $50.97 |
Typical Hold Time | 83 Days | 15 Days |
Enterprise Value | $174.64B | $3.99B |
Dividend Yield | 3.03% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.12, down 0.94% on the day, with strong analyst support showing 85% buy ratings and a $111.20 consensus price target. The stock demonstrates solid revenue growth, reaching $402.07 billion in 2025, though net margins compressed to 1.18%. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 forecast. Technical indicators show a bearish trend with key support at $85.
CVS presents a compelling value opportunity with attractive valuation ratios (P/E 23.17, P/S 0.27) and consistent dividend payments. However, declining profit margins and ongoing regulatory scrutiny pose risks. The company's Medicare expansion and healthcare services growth provide upside potential, but investors should monitor reimbursement pressures and competitive dynamics in the evolving healthcare landscape.
Sezzle (SEZL) surged 9.98% to $125.21, reflecting strong momentum after consistently beating earnings estimates. The stock shows bullish technical signals with robust fundamentals including 51.7% revenue growth in Q2 2026 and exceptional profitability metrics (ROE 88.85%, net margin 30.35%). Recent product launches like Sezzle Send and SezzleCash are driving user growth and platform engagement.
Outlook remains positive with 35% revenue growth guidance and 35.9% upside to consensus price target of $168. Key risks include BNPL competition and potential credit quality concerns, but strong institutional buying and analyst optimism support the bullish case for continued growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Sezzle Inc
Sezzle Inc is a financial technology company that operates a Buy Now, Pay Later (BNPL) payment platform. The company allows consumers to make purchases and split the total cost into four interest-free payments over six weeks, primarily serving the e-commerce retail market. Sezzle focuses on promoting financial empowerment by offering a transparent and responsible payment solution to customers at the point of sale.
Read more on SEZL →
